Status:
COMPLETED
Effect of Ketoconazole on the Pharmacokinetics of Vinflunine
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of the study is to test how ketoconazole affects with handling of vinflunine by the body which might affect how much vinflunine is in the blood stream and for how long
Eligibility Criteria
Inclusion
- Advanced cancer excluding cancer within the blood, adequate kidney and liver function.
Exclusion
- Prior use of vinflunine, other active medical disorders, severe nerve damage
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2007
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00388557
Start Date
October 1 2005
End Date
September 1 2007
Last Update
September 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tennessee Oncology, Pllc
Nashville, Tennessee, United States, 37203